Cargando…

Management of bipolar I depression: clinical utility of lurasidone

Lurasidone is a benzisothiazol derivative second-generation antipsychotic. It has been approved in the United States and Europe for treatment of acute schizophrenia and bipolar depression. In type I bipolar subjects, treatment with lurasidone monotherapy of adjunctive therapy to lithium or valproic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Findlay, Lillian Jan, El-Mallakh, Peggy, El-Mallakh, Rif S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293929/ https://www.ncbi.nlm.nih.gov/pubmed/25609973 http://dx.doi.org/10.2147/TCRM.S57695

Ejemplares similares

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts, Rona Jeannie, et al.
Publicado: (2016)

Role of endogenous ouabain in the etiology of bipolar disorder
por: El-Mallakh, Rif S., et al.
Publicado: (2021)

Current and Emerging Therapies for the Management of Bipolar Disorders
por: El-Mallakh, Rif S., et al.
Publicado: (2011)

Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art
por: El-Mallakh, Rif S., et al.
Publicado: (2022)

Strategies to improve medication adherence in patients with schizophrenia: the role of support services
por: El-Mallakh, Peggy, et al.
Publicado: (2015)

Transdermal Asenapine in Schizophrenia: A Systematic Review
por: Carrithers, Brennan, et al.
Publicado: (2020)

Olfactory Neuroepithelial Neural Progenitor Cells from Subjects with Bipolar I Disorder
por: Gao, Yonglin, et al.
Publicado: (2017)

Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
por: Brown, Martin E, et al.
Publicado: (2010)

Antidepressant discontinuation in treatment resistant depression
por: Ali, Ziad A., et al.
Publicado: (2019)

Cardiac Glycosides in Human Physiology and Disease: Update for Entomologists
por: El-Mallakh, Rif S., et al.
Publicado: (2019)

Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023)

Nebulized Lidocaine in COVID-19, An Hypothesis
por: Ali, Ziad A., et al.
Publicado: (2020)

Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013)

NMDA receptor inhibition prevents intracellular sodium elevations in human olfactory neuroepithelial precursors derived from bipolar patients
por: Gao, Yonglin, et al.
Publicado: (2022)

A case of iloperidone overdose in a 27-year-old man with cocaine abuse
por: Amon, Jin, et al.
Publicado: (2016)

Frequency of Modification of Pharmacological Treatment Is Equivalent for Virtual and In-Person Psychiatric Visits
por: Mumtaz, Amal, et al.
Publicado: (2023)

Lurasidone for the treatment of bipolar depression: an evidence-based review
por: Franklin, Rachel, et al.
Publicado: (2015)

Inhibition of endogenous ouabain by atrial natriuretic peptide is a guanylyl cyclase independent effect
por: Tegin, Gulay, et al.
Publicado: (2021)

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
por: Fornaro, Michele, et al.
Publicado: (2017)

No NLRP3 Inflammasome Expression in the Ouabain Animal Model of Bipolar Disorder
por: Farooqui, Ali A, et al.
Publicado: (2022)

Glial-specific gene alterations associated with manic behaviors
por: Gao, Yonglin, et al.
Publicado: (2013)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Double‐blind, placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
por: Kato, Tadafumi, et al.
Publicado: (2020)

The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey, Philip D
Publicado: (2015)

PS37. Lurasidone in the Treatment of Bipolar Depression: Effect of Baseline Depression Severity on Clinical Outcome
por: Pikalov, Andrei, et al.
Publicado: (2016)

Clinical potential of lurasidone in the management of schizophrenia
por: Samalin, Ludovic, et al.
Publicado: (2011)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression
por: Singh, Manpreet K., et al.
Publicado: (2023)

Patient satisfaction and treatment outcomes as quality indicators for mental health services
por: Howard, Patricia Byrd, et al.
Publicado: (2004)

Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression
por: DelBello, Melissa P., et al.
Publicado: (2021)

TULIP study: Trail of Lurasidone in bipolar disorder in Pakistan()
por: Khan, Nasar, et al.
Publicado: (2021)

Cariprazine exerts antimanic properties and interferes with dopamine D(2) receptor β-arrestin interactions
por: Gao, Yonglin, et al.
Publicado: (2015)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia, Silvio, et al.
Publicado: (2012)

Effects of somatic treatments on suicidal ideation and completed suicides
por: Hawkins, Elise M, et al.
Publicado: (2021)

Chlordiazepoxide-induced delirium in a patient undergoing alcohol withdrawal: a case report
por: Arabadjief, Melissa A., et al.
Publicado: (2022)

Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia
por: Ramesh, Janani, et al.
Publicado: (2020)

Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials
por: Rajagopalan, Krithika, et al.
Publicado: (2016)

Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study
por: Diao, Xiangyuan, et al.
Publicado: (2022)

A diagnostic test to examine early improvement as a predictor of later response to lurasidone in bipolar depression
por: Kishi, Taro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oc8r60p4isrkrg2ejp34h51sg1